amoxicillin has been researched along with Neonatal Sepsis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Benhammou, V; Boileau, P; Charlier, C; Foix L'Helias, L; Gras-Le Guen, C; Kayem, G; Letouzey, M; Lorthe, E; Torchin, H | 1 |
Atkinson, A; Bielicki, J; Fuchs, A; Giannoni, E; Leroux, S; Pfister, M; Rodieux, F; van den Anker, J; van Donge, T | 1 |
Cazanave, C; Charlier, C; Doret Dion, M | 1 |
Barnabas, R; Duke, T; Olita'a, D; Pameh, W; Vali Boma, G; Vince, J | 1 |
Kerr-Liddell, R; Paul, SP; Saito, R | 1 |
5 other study(ies) available for amoxicillin and Neonatal Sepsis
Article | Year |
---|---|
Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation: Perinatal and 2-year outcomes in the EPIPAGE-2 cohort.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cohort Studies; Escherichia coli; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Macrolides; Neonatal Sepsis; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies | 2022 |
Amoxicillin Dosing Regimens for the Treatment of Neonatal Sepsis: Balancing Efficacy and Neurotoxicity.
Topics: Amoxicillin; Anti-Bacterial Agents; Humans; Infant, Newborn; Microbial Sensitivity Tests; Monte Carlo Method; Neonatal Sepsis | 2020 |
[Antibiotic prophylaxis in preterm premature rupture of membranes: CNGOF preterm premature rupture of membranes guidelines].
Topics: Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Erythromycin; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; France; Humans; Infant, Newborn; Neonatal Sepsis; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae | 2018 |
Simplified management protocol for term neonates after prolonged rupture of membranes in a setting with high rates of neonatal sepsis and mortality: a quality improvement study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clinical Protocols; Developing Countries; Drug Resistance, Bacterial; Female; Fetal Membranes, Premature Rupture; Follow-Up Studies; Gentamicins; Humans; Infant, Newborn; Injections, Intramuscular; Male; Medical Overuse; Neonatal Sepsis; Papua New Guinea; Pregnancy; Prenatal Care; Prospective Studies; Quality Improvement; Young Adult | 2019 |
Late onset neonatal sepsis caused by group A streptococcus.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Humans; Infant, Newborn; Male; Neonatal Sepsis; Streptococcal Infections; Streptococcus pyogenes | 2017 |